<sup>18</sup> F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study-Reference-Cited by-同舟云学术

¹⁸ F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study

Published:2024-02 Issue: Volume: Page:
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Cordoba Raul¹,Sánchez-García Joaquín²,Domingo-Domenech Eva³,López Jiménez Javier⁴,Martínez Pozo Antonio⁵,Carpio Cecilia⁶,Bendaña Ángeles⁷,González Ana Julia⁸,González de Villambrosia Sonia⁹,Gómez Codina José¹⁰,Navarro Belén¹¹,Rodríguez Guillermo¹²,Naves Andrea¹³,Baeza Lourdes¹³,Martín García-Sancho Alejandro¹⁴

Affiliation:

1. Lymphoma Unit, Department of Haematology, Health Research Institute IIS-FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain

2. Hematology Department Department, IMIBIC Hospital Universitario Reina Sofía, UCO, Cordoba, Andalucía, Spain

3. Hematology Department, Institut Català D’oncologia, IDIBELL, L’Hospitalet de Llobregat, Spain

4. Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

5. Pathology Department, Hospital Clinic, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Spain

6. Department of Haematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital (HUVH), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

7. Hematology Department, Complexo Hospitalario Universitario de Santiago de Compostela, La Coruña, Spain

8. Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

9. Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain

10. Medical Oncology Department, Hospital Universitari i Politecnic La Fe, Valencia, Spain

11. Hematology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain

12. Hematology Department, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/Universidad de Sevilla, Seville, Spain

13. Medical Department, Takeda Farmacéutica España S.A, Spain

14. Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2024.2313457

Reference40 articles.

1. Swerdlow SH, Campo E, Harris NL, et al. In: Bosman FT, Jaffe ES, Lakhani SR, et al., editors. World health organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed, Revised ed. Lyon, France: International Agency for Research on Cancer; 2017. p. 403–422.

2. The aggressive peripheral T-cell lymphomas: 2017

3. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen

4. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose J;J Clin Oncol

5. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;d’Amore F;Ann Oncol,2015